Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Innocan Pharma Corp C.INNO

Alternate Symbol(s):  INNPF

Healthcare Biotechnology
Innocan Pharma Corporation is an Israel-based company active in the pharmaceuticals and wellness sectors. In the pharmaceuticals sector, the Company aims to provide a safe, non-opioid chronic pain management solutions for both animals and humans. To achieve this aim, the Company developed a CBD-loaded liposome drug delivery platform with exact dosing, prolonged and controlled release of... see more

Recent & Breaking News (CSE:INNO)

Cannabis Industry Investor Conference: Company Executives Present September 8th & 9th

PR Newswire September 2, 2021

Innocan Pharma Received Proceeds of CAD $8.2M from the Exercise of Warrants since January 1, 2021

Newsfile August 27, 2021

Innocan Exercises Option to Enter into a Research and License Agreement with Ramot the Commercial company of the Tel Aviv University

Newsfile August 18, 2021

Ayurcann (CSE:AYUR) to manufacture and distribute Innocan’s (CSE:INNO) CBD topicals in Canada

John Ballem  August 11, 2021

Innocan Engages Ayurcann Inc. to Manufacture and Distribute Innocan's CBD Topicals in Canada

Newsfile August 11, 2021

Innocan Pharma Updates its Progress in the Pre-Clinical Studies of its CBD-Loaded Liposome Platform (LPT)

Newsfile August 3, 2021

Innocan Pharma Announces the Filing of a Patent Application for the Treatment and Prevention of Hair Loss

Newsfile July 28, 2021

Former Israeli Minister of Science and Technology and Highly Influential Venture Capitalist to Join Innocan Pharma's Advisory Committee

Newsfile July 14, 2021

Innocan Pharma Announces Filing of International Patent Application for Topical Treatment for Diabetic Symptoms

Newsfile July 9, 2021

Innocan Pharma and Health Investment Group S.A. Sign Exclusive Distribution Agreement for Poland

Newsfile July 1, 2021

Innocan Pharma's CBD Integrated Anti-Aging Sleeping Mask Demonstrates a Reduction of the Appearance of Wrinkles by up to 28.8% in 4 Weeks of Clinical Study

Newsfile June 24, 2021

Innocan Pharma Corporation to Webcast Live at Life Sciences Investor Forum June 24th

GlobeNewswire June 21, 2021

Clinical Study Validates Innocan Pharma's SHIR(R) CBD Eye Serum as an Anti-Puffiness Solution

Newsfile June 16, 2021

Innocan Pharma Announces Patent Application for Novel Cannabis-Based Vaginal Moisturizer and Lubricant Treatment

Newsfile June 14, 2021

InnoCan Pharma tests (CSE:INNO) Liposome Platform Technology for CBD

Trevor Abes  June 11, 2021

Innocan Pharma's Liposome Platform Technology Demonstrates a 7-Week Prolonged Release of CBD into Bloodstream in Recent Animal Study

Newsfile June 11, 2021

Innocan Pharma Among Leading CBD Pharma Companies to Participate at Lytham Partners Summer 2021 Investor Conference

Newsfile June 9, 2021

Innocan Pharma’s (CSE:INNO) CBD loaded liposome platform technology receives positive results

Brieanna McCutcheon  May 14, 2021

Innocan Pharma's CBD Loaded Liposome Platform Technology Receives Positive Results from Recent Animal Study

Newsfile May 14, 2021

Innocan Pharma Engages Lytham Partners to Lead Investor Relations and Shareholder Communication Program

Newsfile May 10, 2021